WT1 and acute myeloid leukemia: Wilms' tumor 1 (<i>WT1</i>) is overexpressed in most AML cases and represents a broadly applicable molecular marker; however, its utility as a peripheral blood (PB) measurable residual disease (MRD) marker after allo-HSCT remains incompletely defined.